UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (8,128)	$ (2,703)
Loss from discontinued operations, net of income taxes	(658)	(680)
Loss from continuing operations, net of income taxes	(7,470)	(2,023)
Adjustments to reconcile loss from continuing operations, net of income taxes to net cash provided by (used in) operating activities:
Depreciation	2,459	1,931
Amortization of intangibles	2,082	879
Change in deferred income tax	457	(300)
Amortization of deferred financing costs	356	284
Compensation under stock-based compensation plans	1,973	966
Loss on disposal of fixed assets	13	23
Changes in assets and liabilities, net of amounts acquired in acquisitions:
Receivables, net of bad debt expense	(16,526)	(16,761)
Inventory	13,199	4,215
Prepaid expenses and other assets	2,487	4,238
Accounts payable	(2,822)	5,587
Claims payable	187	(6,598)
Amounts due to plan sponsors	(4,140)	(874)
Accrued expenses and other liabilities	(4,445)	4,557
Net cash used in operating activities from continuing operations	(12,190)	(3,876)
Net cash (used on) provided by operating activities from discontinued operations	(658)	6,401
Net cash (used in) provided by operating activities	(12,848)	2,525
Cash flows from investing activities:
Purchases of property and equipment, net	(3,655)	(1,547)
Cash consideration paid for acquisitions, net of cash acquired	(72,325)	0
Cash consideration paid to DS Pharmacy	0	(2,935)
Cash consideration paid for unconsolidated affiliate, net of cash acquired	(900)	0
Net cash used in investing activities from continuing operations	(76,880)	(4,482)
Net cash provided by investing activities from discontinued operations	0	2,741
Net cash used in investing activities	(76,880)	(1,741)
Cash flows from financing activities:
Borrowings on line of credit	214,145	481,151
Repayments on line of credit	(187,092)	(483,224)
Repayments of capital leases	(68)	(35)
Net proceeds from exercise of employee stock compensation plans	642	1,324
Net cash provided by (used in) financing activities	27,627	(784)
Net change in cash and cash equivalents	(62,101)	0
Cash and cash equivalents - beginning of period	62,101	0
Cash and cash equivalents - end of period	0	0
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	322	1,241
Cash paid during the period for income taxes	(6)	197
DISCLOSURE OF NON-CASH TRANSACTIONS:
Capital lease obligations incurred to acquire property and equipment	$ 0	$ 20